Article Details
Retrieved on: 2024-10-30 22:08:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Remternetug, an N3pH-Aß monoclonal antibody, is a follow-on to donanemab, Eli Lilly's approved anti-amyloid antibody also designed against ...
Article found on: www.neurologylive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here